313 related articles for article (PubMed ID: 17377186)
1. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Inoue K; Nakamura K; Inoue Y
J Vasc Interv Radiol; 2007 Mar; 18(3):399-404. PubMed ID: 17377186
[TBL] [Abstract][Full Text] [Related]
2. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
[TBL] [Abstract][Full Text] [Related]
3. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
Linden PA; Wee JO; Jaklitsch MT; Colson YL
Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
[TBL] [Abstract][Full Text] [Related]
4. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?
Hiraki T; Mimura H; Gobara H; Sano Y; Fujiwara H; Date H; Kanazawa S
J Vasc Interv Radiol; 2008 May; 19(5):706-11. PubMed ID: 18440459
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan.
Yamakado K; Hase S; Matsuoka T; Tanigawa N; Nakatsuka A; Takaki H; Takao M; Inoue Y; Kanazawa S; Inoue Y; Sawada S; Kusunoki M; Takeda K
J Vasc Interv Radiol; 2007 Mar; 18(3):393-8. PubMed ID: 17377185
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
7. Needle tract seeding after radiofrequency ablation of hepatic tumors.
Jaskolka JD; Asch MR; Kachura JR; Ho CS; Ossip M; Wong F; Sherman M; Grant DR; Greig PD; Gallinger S
J Vasc Interv Radiol; 2005 Apr; 16(4):485-91. PubMed ID: 15802448
[TBL] [Abstract][Full Text] [Related]
8. CT-guided radiofrequency heat ablation of malignant lung tumors.
Schaefer O; Lohrmann C; Ghanem N; Langer M
Med Sci Monit; 2003 Nov; 9(11):MT127-31. PubMed ID: 14586288
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors influencing the development of an iatrogenic pneumothorax for computed tomography-guided radiofrequency ablation of upper renal tumor.
Park BK; Kim CK
Acta Radiol; 2008 Dec; 49(10):1200-6. PubMed ID: 19031183
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency thermal ablation in the treatment of lung malignancies.
Gadaleta C; Catino A; Mattioli V
In Vivo; 2006; 20(6A):765-7. PubMed ID: 17203764
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.
Pennathur A; Luketich JD; Abbas G; Chen M; Fernando HC; Gooding WE; Schuchert MJ; Gilbert S; Christie NA; Landreneau RJ
J Thorac Cardiovasc Surg; 2007 Oct; 134(4):857-64. PubMed ID: 17903496
[TBL] [Abstract][Full Text] [Related]
12. Image-guided radiofrequency ablation (RFA) of spinal tumors.
Gevargez A; Groenemeyer DH
Eur J Radiol; 2008 Feb; 65(2):246-52. PubMed ID: 17524585
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
[TBL] [Abstract][Full Text] [Related]
14. Risk factors involved in the development of pneumothorax during radiofrequency ablation of lung neoplasms.
Nour-Eldin NE; Naguib NN; Saeed AS; Ackermann H; Lehnert T; Korkusuz H; Vogl TJ
AJR Am J Roentgenol; 2009 Jul; 193(1):W43-8. PubMed ID: 19542382
[TBL] [Abstract][Full Text] [Related]
15. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous computed tomography-guided biopsy and radiofrequency ablation of solitary pulmonary malignancy in high-risk patients.
Schneider T; Puderbach M; Kunz J; Bischof A; Giesel FL; Dienemann H; Herth FJ; Schnabel PA; Safi S; Hoffmann H; Heussel CP
Respiration; 2012; 84(6):501-8. PubMed ID: 23037897
[TBL] [Abstract][Full Text] [Related]
17. Comparative survival analysis in patients with pulmonary metastases from nasopharyngeal carcinoma treated with radiofrequency ablation.
Pan CC; Wu PH; Yu JR; Li W; Huang ZL; Wang JP; Zhao M
Eur J Radiol; 2012 Apr; 81(4):e473-7. PubMed ID: 21700408
[TBL] [Abstract][Full Text] [Related]
18. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term.
Ambrogi MC; Lucchi M; Dini P; Melfi F; Fontanini G; Faviana P; Fanucchi O; Mussi A
Eur J Cardiothorac Surg; 2006 Jul; 30(1):177-83. PubMed ID: 16723242
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
Soga N; Yamakado K; Gohara H; Takaki H; Hiraki T; Yamada T; Arima K; Takeda K; Kanazawa S; Sugimura Y
BJU Int; 2009 Sep; 104(6):790-4. PubMed ID: 19338555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
